From November 20, 2023 to December 31, 2023, the company has repurchased 7,201,500 shares, representing 1.35% for CNY 95.84 million. With this, the company has completed the repurchase of 7,201,500 shares, representing 1.35% for CNY 95.84 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.34 CNY | +0.86% | +1.97% | -30.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.45% | 687M | |
-4.93% | 261B | |
-2.51% | 94.98B | |
+3.19% | 46.39B | |
+8.74% | 39.99B | |
-0.15% | 38.02B | |
-16.78% | 30.16B | |
-6.61% | 28.72B | |
+11.32% | 24.54B | |
-9.29% | 22.65B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.